TickerFactsScreenerDevelopers

Protagonist Therapeutics, Inc (PTGX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$14.38M2016: -$29.97M2017: $3.87M2018: -$49.95M2019: -$41.53M2020: -$72.48M2021: -$107.86M2022: -$108.14M2023: -$70.24M2024: $184.15M2025: $57.67M$57.67M
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$57.67M-68.7%
2024$184.15M+362.2%
2023-$70.24M+35.0%
2022-$108.14M-0.3%
2021-$107.86M-48.8%
2020-$72.48M-74.5%
2019-$41.53M+16.9%
2018-$49.95M-1390.0%
2017$3.87M+112.9%
2016-$29.97M-108.4%
2015-$14.38M—